To assess the impact of hospital volume (HV) and surgeon volume (SV) on perioperative outcomes of robot-assisted partial nephrectomy (RAPN).
Patients and Methods
All consecutive patients who underwent a RAPN from 2009 to 2015, at 11 institutions, were included in a retrospective study. To evaluate the impact of HV, we divided RAPN into four quartiles according to the caseload per year: low HV (<20/year), moderate HV (20-44/year), high HV (45-70/ year), and very high HV (>70/year). The SV was also divided into four quartiles: low SV (<7/year), moderate SV (7-14/ year), high SV (15-30/year), and very high SV (>30/year). The primary endpoint was the Trifecta defined as the following combination: no complications, warm ischaemia time (WIT) <25 min, and negative surgical margins.
Results
In total, 1 222 RAPN were included. The mean (SD) caseload per hospital per year was 44.9 (26.7) RAPNs and the mean (SD) caseload per surgeon per year was 19.2 (14.9) RAPNs. The Trifecta achievement rate increased significantly with SV (69.9% vs 72.8% vs 73% vs 86.1%; P < 0.001) and HV (60.3% vs 72.3% vs 86.2% vs 82.4%; P < 0.001). The positive surgical margins (PSM) rate (P = 0.02), length of hospital stay (LOS; P < 0.001), WIT (P < 0.001), and operative time (P < 0.001), all decreased significantly with increasing SV. The PSM rate (P = 0.02), LOS (P < 0.001), WIT (P < 0.001), operative time (P < 0.001), and major complications rate (P = 0.01), all decreased significantly with increasing HV. In multivariate analysis adjusting for HV and SV (model 3), HV remained the main predictive factor of Trifecta achievement (odds ratio [OR] 3.70 for very high vs low HV; P < 0.001), whereas SV was not associated with Trifecta achievement (OR 1.58 for very high vs low SV; P = 0.34).
Introduction
The impact of surgeon volume (SV) and hospital volume (HV) on perioperative and oncological outcomes has been shown for numerous surgical procedures. Radical cystectomy, radical prostatectomy and partial nephrectomy (PN) are considered as the most complex urological procedures. Recently, Leow et al. [1] reported in a recent systematic review that higher SV was associated with improved outcomes for radical prostatectomy. Numerous series have suggested a similar association for radical cystectomy [2] . Very little data exist concerning volume outcomes in nephron-sparing surgery (NSS) in general and especially concerning robot-assisted PN (RAPN) [3] .
Partial nephrectomy is now considered as the standard of care for the management of small renal masses [4] . PN is usually seen as a complex procedure and a challenge for surgeons with low experience. Most surgical teams have evolved towards minimally invasive NSS. The robotic approach has become the preferred approach for minimally invasive PN because it is less technically challenging than laparoscopic PN [5, 6] and numerous studies clearly favoured the robotic approach in terms of perioperative morbidity [7] .
The question of whether provider volume influences surgical outcomes has become prominent in an era of costeffectiveness [8, 9] . In a recent study, Khandwala et al. [10] suggested that the in-hospital RAPN costs were lower for higher volume surgeons.
The objective of the present study was to assess the impact of HV and SV on perioperative outcomes of RAPN.
Patients and Methods

Study Design
All consecutive patients who underwent a PN from 2009 to 2015, at 11 institutions, were included in this retrospective study. Only RAPNs were included (i.e. exclusion of open and laparoscopic PN). Standardisation of surgical techniques was not possible due to the multicentre and retrospective design of the study. However, the use of arterial clamping (i.e. onclamp vs off-clamp PN) [11] , the use of the early unclamping technique [12] , as well as the approach used (i.e. retroperitoneal vs transperitoneal), were recorded as surrogates of the surgical technique used in each centre.
For each patient, demographics, age, gender, American Society of Anesthesiologists (ASA) classification, body mass index (BMI), history of cardiovascular disease, Eastern Cooperative Oncology Group (ECOG) score, preoperative estimated GFR (eGFR) and tumour characteristics (tumour size, histological type, tumour complexity evaluated by the R.E.N.A.L. [Radius; Exophytic/Endophytic; Nearness; Anterior/Posterior; Location] nephrometry score [13] ), were collected. Indications for NSS were categorised as imperative (i.e. single kidney or preoperative eGFR of <60 mL/min/ 1.73 m²) or elective (no imperative criteria).
This study involved the French Research Network for Kidney Cancer (UroCCR, NCT03293563) and was conducted in accordance with the guidelines of the Helsinki Declaration.
Provider Volume
Hospital volumes and SVs were calculated for each procedure on a year per year basis. To evaluate the impact of HV we divided RAPNs into four quartiles according to the caseload per year: low HV (<20/year), moderate HV (20-44/year), high HV (45-70/year), and very high HV (>70/year). The SV was also divided into four quartiles: low SV (<7/year), moderate SV (7-14/year), high SV (15-30/year), and very high SV (>30/year). The surgeon's experience was also collected and categorised as: <20, 20-50, and >50 procedures.
Outcomes
The primary endpoint was the Trifecta defined as the following combination: no complications, warm ischaemia time (WIT) of <25 min, and negative surgical margins [14] . Postoperative complications were graded using the ClavienDindo classification [15, 16] and reported according to the European Association of Urology (EAU) guidelines [14] . Major complications were defined as a Clavien-Dindo grade of ≥III. Haemorrhagic complications were defined, as previously described [7] as one of the following events: pseudo-aneurysm, arteriovenous fistula, bleeding requiring reoperation or haematoma requiring blood transfusion. The other outcomes of interest were WIT, operative time, estimated blood loss, transfusion requirement, length of hospital stay (LOS), and surgical margin status.
Statistical Analysis
Means with standard deviations (SDs) were reported for continuous variables and proportions for nominal variables. Comparisons between groups were performed using the chisquared test for discrete variables and ANOVA for continuous variables.
Logistic regression univariate and multivariate analyses were used to evaluate predictors of Trifecta. For each outcome, we generated three different models, including either SV (model 1), HV (model 2), or both (model 3). Multivariable models included covariates with a P < 0.2 in univariable analysis. For continuous variables, odds ratios (ORs) were expressed as a range (per change in regressor over entire range). Statistical analyses were performed using JMP v.12.0 software (SAS Institute Inc., Cary, NC, USA). All tests were two-sided with a significance level of P < 0.05.
Results
Patients' Characteristics
In total, 1 222 RAPNs were included. The mean (SD) caseload per hospital per year was 44.9 (26.7) RAPNs and the mean (SD) caseload per surgeon per year was 19.2 (14.9) RAPNs. The patients' and tumour characteristics according to the SV are summarised in Table 1 . Mean patients' age, gender, BMI, indications (elective vs imperative), and mean tumour size were similar in the four groups (low, moderate, high, and very high SV) but, as expected, surgeon's experience increased significantly with SV (>50 cases: 0.8% vs 4.7% vs 8.9% vs 97.6%; P < 0.001). The mean R.E.N.A.L. score was lower in low-and moderate-volume surgeons compared to their high and very high counterparts (6.5 vs 6.4 vs 7.0 vs 7.4; P < 0.001). The patients' and tumour characteristics according to HV are presented in Table 2 . Mean patients' age, gender, BMI, and mean tumour size were similar in the four groups (low, moderate, high, and very high HV) but, as expected, surgeon's experience increased significantly with HV (>50 cases: 0.4% vs 11.2% vs 40.9% vs 51.3%; P < 0.001). The mean R.E.N.A.L. score was lower in low-volume hospitals compared to their moderate, high, and very high counterparts (6 vs 6.8 vs 6.9 vs 7.4; P < 0.001).
Impact of Provider Volume on Surgical Technique Used
Both SV and HV had a significant impact on the use of a retroperitoneal approach, with retroperitoneal RAPN rate increasing significantly with higher SV (5.3% vs 0% vs 10.4% vs 15.1%; P < 0.001) and higher HV (2.5% vs 6.3% vs 7.9% vs 11.5%; P < 0.001). Likewise, the early unclamping technique was used more frequently with increasing SV (53.9% vs 51.5% vs 59.4% vs 90.4%; P < 0.001) and in hospitals with higher volumes (24.3% vs 50% vs 65.1% vs 91%; P < 0.001). Conversely, the use of an off-clamp technique was similar regardless of SV (6% vs 5% vs 7.6% vs 2.6%; P = 0.09) or HV (4.1% vs 6.4% vs 5.4% vs 4.8%; P = 0.62).
Impact of SV
The Trifecta achievement rate increased significantly with SV (69.9% vs 72.8% vs 73% vs 86.1%; P < 0.001; Fig. 1 (Table 3) . Conversely, there were no statistically significant differences between groups in terms of the complications rate (18.1% vs 18.6% vs 15.9% vs 16.1%; P = 0.81) or major complications rate (6.4% vs 5.9% vs 6% vs 3.2%; P = 0.54).
In univariate analysis, tumour size (OR 0.19; P < 0.001), surgeon's experience (OR 2.09 for >50 cases vs <20 cases; P < 0.001) and very high SV (OR 2.65 for very high vs low SV; P < 0.001) were statistically associated with Trifecta achievement (Table 4 ). In multivariate analysis adjusting for surgeon's experience and R.E.N.A.L. score (model 1); tumour size (OR 0.15; P < 0.001) and very high SV (OR 3.45 for very high vs low SV; P = 0.005) remained the only predictors of Trifecta achievement.
Impact of HV
The Trifecta achievement rate increased significantly with HV (60.3% vs 72.3% vs 86.2% vs 82.4%; P < 0.001; Fig. 1 ). The PSM rate (10.5% vs 5.6% vs 5.6% vs 3.6%; P = 0.02), LOS (6 vs 4.2 vs 4.7 vs 4 days; P < 0.001), WIT (20.3 vs 16.6 vs 15.4 vs 14 min; P < 0.001), operative time (181.3 vs 158.4 vs 149.6 vs 131 min; P < 0.001), and major complications rate (12.1% vs 7.6% vs 4.2% vs 5.2%; P = 0.01), all decreased significantly with increasing HV (Table 5) . Conversely, the difference between groups in terms of the complications rate did not reach statistical significance (19.6% vs 19.1% vs 12.5% vs 17.5%; P = 0.11). In univariate analysis, HV was strongly associated with Trifecta achievement (OR 3.09 for very high vs low HV; P < 0.001). In multivariate analysis adjusting for surgeon's experience, tumour size, and R.E.N.A.L. score (model 2); HV remained the stronger predictor of Trifecta achievement (OR 3.84 for very high vs low HV; P < 0.001; Table 6 ). The two other predictive factors of Trifecta achievement were tumour size (OR 0.22; P = 0.007) and R.E.N.A.L. score (OR 0.43; P = 0.03).
Relative role of SV and HV
In multivariate analysis adjusting for both HV and SV (model 3), HV remained the main predictive factor of Trifecta achievement (OR 3.70 for very high vs low HV; P < 0.001; Table 7 ), whereas SV was not associated with Trifecta achievement (OR 1.58 for very high vs low SV; P = 0.34).
The two other predictors of Trifecta achievement were tumour size (OR 0.21; P = 0.006) and R.E.N.A.L. score (OR 0.44; P = 0.04).
Discussion
In the management of small renal masses, NSS should be attempted when technically feasible [4] . The robotic approach has been widely adopted over the past 10 years and has allowed the treatment of more complex tumours and to expand the indications of minimally invasive PN [17] . It is well-known that RAPN is technically challenging and associated with a significant risk of complications, albeit this complication rate remains lower than the open approach [18] . Despite many studies having assessed the relationship between provider volume and RAPN outcomes [19, 20] , to our knowledge no study to date has analysed both HV and SV.
In one of the core publications in the field of volumeoutcome relationships in surgery, Birkmeyer et al. [21] reported in 2003 that for many surgical procedures the observed associations between HV and operative mortality could be largely mediated by SV. Conversely, in the present study HV appeared to be the key determinant of RAPN outcomes. This may be explained by a standardisation of the surgical technique in the high-volume institutions but it is likely that the standardised management of small renal masses pre-and postoperatively in general in these tertiary centres might be the major factor underlying HV influence. In fact in these centres, every resident, fellow, and nurse knows how to manage a patient before and after the surgery because it relies on the institutions' protocol. Increased use of fast-track/enhanced recovery in tertiary centres may also play a role [22] . Another possible contributor to HV-outcome relationship might have been the easier access in larger institutions to radio-embolisation but this technique was available in all centres included in the present study. All these factors, along with the fact that the Birkmeyer et al. [21] study included several surgical procedures but not PN, could explain the difference between our present findings and those of Birkmeyer et al. 15 years ago regarding the relative importance of HV and SV.
We found that the complications rate did not differ significantly according to SV. A possible explanation could be the academic setting of our present study with low-volume surgeons being mostly fellows. Junior surgeons with a lower case volume were usually supervised by senior surgeons to ensure proper teaching and patient's safety [23] , which may have hidden or tempered the influence of SV on perioperative outcomes in the present dataset. In a recent publication, it seems that training fellows to perform RAPN is associated with longer operating time and WIT but does not seem to compromise other perioperative outcomes [23] . Hence, our present findings might not be applicable to non-teaching structures.
It has to be emphasised that all cases from the participating institutions were included, from their very first case; therefore this series includes their early learning curves. Now that RAPN has been widely used for over a decade in most centres [7] , one might assume the surgical technique has been standardised and might be reproducible even by surgeons/ institutions of lower volume.
Another interesting finding in our present series was the influence of HV and SV on patients' characteristics, with higher provider volume being associated with more comorbidities (higher rates of patients with ASA scores of III) and more complex renal masses (as assessed by the R.E.N.A.L. score), which might be a reflection of a greater experience and confidence in performing RAPN favouring wider use of NSS compared to radical nephrectomy and ablative treatments. It could also result from more selective referral of complex cases to larger centres.
Hospital volume and SV are increasingly used as determinants of quality of care with the theory that repetition leads to minimised errors [1] [2] [3] 10, 21] . In this way of management, a challenging surgical procedure such as PN may be attributed to a restricted number of referral centres and to fewer surgeons, despite envisaging that this centralisation of care could encounter resistance and generate conflicts amongst urologists. In that regard, as most outcomes keep improving until the 30 cases/surgeon/year threshold, this could be proposed as the hypothetical minimum number of RAPNs for a single surgeon to perform annually to ensure optimal outcomes. Likewise, 45 cases/institution/year could be regarded as the minimum threshold to reach for HV according to our present findings. However, such thresholds are always somewhat subjectively defined, even when relying on statistical analysis of a large series because it depends mostly on which outcomes are specifically chosen to define optimal outcomes. Another point of interest that could have translated practically into daily practice could have been to find a threshold of the minimum number of cases needed to overcome RAPN learning curves. Unfortunately, the design of the present study could not directly answer this question because it would have required us to specifically address the learning curve of each surgeon and too few of the surgeons involved in the present study would have performed enough cases to assess properly in a multivariate way for such a threshold. Hence, in a recent study, 60 procedures were necessary to obtain the outcomes of an expert surgeon, but the bootstrapping analysis allowed the estimation that perioperative outcomes could keep improving until the 500th procedure, suggesting a longer learning curve than presumed [24] .
The present study has several limitations that should be acknowledged. The major shortcomings were those inherent to its retrospective and nonrandomised design. The multicentre nature of the study may also be considered a drawback, as the surgical technique and perioperative management were not standardised between centres. We tried our best to address the possible differences in terms of surgical technique used according to HV and SV by reporting the use of arterial clamping, early unclamping, and retroperitoneal vs transperitoneal approach across all groups. Unfortunately, data regarding the resection technique used (i.e. enucleation vs 'standard' PN with a 'safety' rim of parenchyma adjacent to the tumour) was not available in the operative reports and the distribution of enucleation use according to HV and SV could therefore not be reported, which could be regarded as a shortcoming of the present study considering the growing interest in enucleation and its possible impact on PN outcomes [25] . Data regarding the number of PNs performed via another approach (open of laparoscopic) by each surgeon/institution were not available, which prevented adjustment for this possible confounder. The lack of statistical power due to the relatively limited number of disease recurrences prevented assessment of the impact of volume providers on oncological outcomes.
Conclusion
In the present multicentre study, HV and SV both greatly influenced RAPN perioperative outcomes notably Trifecta achievement, WIT, operative time, LOS, and PSM rate. By influencing the major postoperative complications rate (conversely to SV) and by remaining the strongest predictors of Trifecta achievement in all multivariate models, HV appears to have greater impact on RAPN perioperative outcomes than SV. Hence, to accredit only high-volume centres to perform RAPN might contribute to improving outcomes and cost-effectiveness.
